Release of mycobacterial antigens

Immunological Reviews

Volumn 264, Issue 1, 2015, Pages 25-45

  Majlessi, Laleh ^a   Prados Rosales, Rafael ^b   Casadevall, Arturo ^b   Brosch, Roland ^a  

^a INSTITUT PASTEUR   (France)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ESX; Antigens; Mycobacterium tuberculosis; PE PPE; Secretion; Vesicles

Indexed keywords

CULTURE FILTRATE PROTEIN 10; MYCOBACTERIUM ANTIGEN; SIGNAL PEPTIDE; ADENOSINE TRIPHOSPHATASE; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL SECRETION SYSTEM; CARRIER PROTEIN; SECA PROTEIN, BACTERIA;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL VIRULENCE; ESX 1 SYSTEM; ESX 2 SYSTEM; ESX 3 SYSTEM; ESX 4 SYSTEM; ESX 5 SYSTEM; HOST PATHOGEN INTERACTION; MEMBRANE VESICLE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTER MEMBRANE; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN SECRETION; SECRETORY PATHWAY; TWIN ARGININE TRANSLOCATION; ANIMAL; BACTERIAL SECRETION SYSTEM; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; SECRETORY VESICLE; TRANSPORT AT THE CELLULAR LEVEL; TUBERCULOSIS;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; BIOLOGICAL TRANSPORT; HUMANS; MEMBRANE TRANSPORT PROTEINS; MYCOBACTERIUM TUBERCULOSIS; SECRETORY PATHWAY; SECRETORY VESICLES; TUBERCULOSIS;

EID: 84923206659     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12251     Document Type: Article

References (206)

1. Kaur D, Guerin ME, Skovierova H, Brennan PJ, Jackson M. Chapter 2: biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. Adv Appl Microbiol 2009;69:23-78.
2. Zuber B, Chami M, Houssin C, Dubochet J, Griffiths G, Daffe M. Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J Bacteriol 2008;190:5672-5680.
3. Hoffmann C, Leis A, Niederweis M, Plitzko JM, Engelhardt H. Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci USA 2008;105:3963-3967.
4. Sambou T, et al. Capsular glucan and intracellular glycogen of Mycobacterium tuberculosis: biosynthesis and impact on the persistence in mice. Mol Microbiol 2008;70:762-774.
5. Sani M, et al. Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog 2010;6:e1000794.
6. Orme IM. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun 1988;56:3310-3312.
7. Romain F, Augier J, Pescher P, Marchal G. Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunised with living mycobacteria. Proc Natl Acad Sci USA 1993;90:5322-5326.
8. Andersen P. The T cell response to secreted antigens of Mycobacterium tuberculosis. Immunobiology 1994;191:537-547.
9. Cole ST, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-544.
10. Jungblut PR, et al. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 1999;33:1103-1117.
11. Malen H, Berven FS, Fladmark KE, Wiker HG. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 2007;7:1702-1718.
12. Tekaia F, Gordon SV, Garnier T, Brosch R, Barrell BG, Cole ST. Analysis of the proteome of Mycobacterium tuberculosis in silico. Tuber Lung Dis 1999;79:329-342.
13. Gey Van Pittius NC, Gamieldien J, Hide W, Brown GD, Siezen RJ, Beyers AD. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol 2001;2:RESEARCH0044.
14. Comas I, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010;42:498-503.
15. Supply P, et al. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet 2013;45:172-179.
16. Pugsley AP. The complete general secretory pathway in gram-negative bacteria. Microbiol Rev 1993;57:50-108.
17. Braunstein M, Espinosa BJ, Chan J, Belisle JT, Jacobs WR Jr. SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol Microbiol 2003;48:453-464.
18. van der Woude AD, Luirink J, Bitter W. Getting across the cell envelope: mycobacterial protein secretion. Curr Top Microbiol Immunol 2013;374:109-134.
19. van der Woude AD, et al. Analysis of SecA2-dependent substrates in Mycobacterium marinum identifies protein kinase G (PknG) as a virulence effector. Cell Microbiol 2014;16:280-295.
20. Gerlach RG, Hensel M. Protein secretion systems and adhesins: the molecular armory of Gram-negative pathogens. Int J Med Microbiol 2007;297:401-415.
21. Niederweis M, Danilchanka O, Huff J, Hoffmann C, Engelhardt H. Mycobacterial outer membranes: in search of proteins. Trends Microbiol 2010;18:109-116.
22. Danilchanka O, et al. An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity. Proc Natl Acad Sci USA 2014;111:6750-6755.
23. Boritsch EC, Supply P, Honore N, Seeman T, Stinear TP, Brosch R. A glimpse into the past and predictions for the future: the molecular evolution of the tuberculosis agent. Mol Microbiol 2014;16:12720.
24. McDonough JA, Hacker KE, Flores AR, Pavelka MS Jr, Braunstein M. The twin-arginine translocation pathway of Mycobacterium smegmatis is functional and required for the export of mycobacterial beta-lactamases. J Bacteriol 2005;187:7667-7679.
25. Saint-Joanis B, et al. Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. J Bacteriol 2006;188:6669-6679.
26. Ligon LS, Hayden JD, Braunstein M. The ins and outs of Mycobacterium tuberculosis protein export. Tuberculosis 2012;92:121-132.
27. Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003;48:77-84.
28. Griffin JE, Gawronski JD, Dejesus MA, Ioerger TR, Akerley BJ, Sassetti CM. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog 2011;7:e1002251.
29. Berks BC, Sargent F, Palmer T. The Tat protein export pathway. Mol Microbiol 2000;35:260-274.
30. McDonough JA, McCann JR, Tekippe EM, Silverman JS, Rigel NW, Braunstein M. Identification of functional Tat signal sequences in Mycobacterium tuberculosis proteins. J Bacteriol 2008;190:6428-6438.
31. Ronning DR, Klabunde T, Besra GS, Vissa VD, Belisle JT, Sacchettini JC. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat Struct Biol 2000;7:141-146.
32. Solans L, et al. The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis. PLoS Pathog 2014;10:e1004183.
33. Raynaud C, et al. Phospholipases C are involved in the virulence of Mycobacterium tuberculosis. Mol Microbiol 2002;45:203-217.
34. Pallen MJ. The ESAT-6/WXG100 superfamily - and a new Gram-positive secretion system? Trends Microbiol 2002;10:209-212.
35. Brodin P, Rosenkrands I, Andersen P, Cole ST, Brosch R. ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol 2004;12:500-508.
36. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995;63:1710-1717.
37. Berthet FX, Rasmussen PB, Rosenkrands I, Andersen P, Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 1998;144:3195-3203.
38. Abdallah AM, et al. Type VII secretion system of mycobacteria show the way. Nat Rev Microbiol 2007;5:883-891.
39. Bitter W, et al. Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog 2009;5:e1000507.
40. Bitter W, Houben EN, Luirink J, Appelmelk BJ. Type VII secretion in mycobacteria: classification in line with cell envelope structure. Trends Microbiol 2009;17:337-338.
41. Gray TA, Krywy JA, Harold J, Palumbo MJ, Derbyshire KM. Distributive conjugal transfer in mycobacteria generates progeny with meiotic-like genome-wide mosaicism, allowing mapping of a mating identity locus. PLoS Biol 2013;11:e1001602.
42. Cascales E, Atmakuri K, Sarkar MK, Christie PJ. DNA substrate-induced activation of the Agrobacterium VirB/VirD4 type IV secretion system. J Bacteriol 2013;195:2691-2704.
43. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996;178:1274-1282.
44. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996;64:16-22.
45. Behr MA, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284:1520-1523.
46. Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole ST. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 1999;32:643-656.
47. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 2002;46:709-717.
48. Pym AS, et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003;9:533-539.
49. Young DB. Building a better tuberculosis vaccine. Nat Med 2003;9:503-504.
50. Hsu T, et al. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA 2003;100:12420-12425.
51. Lewis KN, et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 2003;187:117-123.
52. Stanley SA, Raghavan S, Hwang WW, Cox JS. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci USA 2003;100:13001-13006.
53. Sassetti CM, Rubin EJ. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 2003;100:12989-12994.
54. Wards BJ, de Lisle GW, Collins DM. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Tuber Lung Dis 2000;80:185-189.
55. Guinn KM, et al. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol 2004;51:359-370.
56. Renshaw PS, et al. Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J 2005;24:2491-2498.
57. Renshaw PS, et al. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence. J Biol Chem 2002;277:21598-21603.
58. Brodin P, et al. Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J Biol Chem 2005;280:33953-33959.
59. Houben EN, Korotkov KV, Bitter W. Take five - Type VII secretion systems of Mycobacteria. Biochim Biophys Acta 2014;1844:1707-1716.
60. Simeone R, et al. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog 2012;8:e1002507.
61. Champion PA, Stanley SA, Champion MM, Brown EJ, Cox JS. C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis. Science 2006;313:1632-1636.
62. Daleke MH, et al. General secretion signal for the mycobacterial type VII secretion pathway. Proc Natl Acad Sci USA 2012;109:11342-11347.
63. Strong M, Sawaya MR, Wang S, Phillips M, Cascio D, Eisenberg D. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006;103:8060-8065.
64. van der Woude AD, et al. Unexpected link between lipooligosaccharide biosynthesis and surface protein release in Mycobacterium marinum. J Biol Chem 2012;287:20417-20429.
65. Demangel C, et al. Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. Infect Immun 2004;72:2170-2176.
66. Brodin P, et al. Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun 2006;74:88-98.
67. Chen JM, et al. Mycobacterium tuberculosis EspB binds phospholipids and mediates EsxA-independent virulence. Mol Microbiol 2013;89:1154-1166.
68. Fortune SM, et al. Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci USA 2005;102:10676-10681.
69. Houben EN, et al. Composition of the type VII secretion system membrane complex. Mol Microbiol 2012;86:472-484.
70. Ohol YM, Goetz DH, Chan K, Shiloh MU, Craik CS, Cox JS. Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence. Cell Host Microbe 2010;7:210-220.
71. Carlsson F, Joshi SA, Rangell L, Brown EJ. Polar localization of virulence-related Esx-1 secretion in mycobacteria. PLoS Pathog 2009;5:e1000285.
72. Champion PA, Champion MM, Manzanillo P, Cox JS. ESX-1 secreted virulence factors are recognized by multiple cytosolic AAA ATPases in pathogenic mycobacteria. Mol Microbiol 2009;73:950-962.
73. McLaughlin B, et al. A mycobacterium ESX-1-secreted virulence factor with unique requirements for export. PLoS Pathog 2007;3:e105.
74. Bottai D, et al. ESAT-6 secretion-independent impact of ESX-1 genes espF and espG1 on virulence of Mycobacterium tuberculosis. J Infect Dis 2011;203:1155-1164.
75. Zhang M, Chen JM, Sala C, Rybniker J, Dhar N, Cole ST. EspI regulates the ESX-1 secretion system in response to ATP levels in Mycobacterium tuberculosis. Mol Microbiol 2014;15:12718.
76. MacGurn JA, Raghavan S, Stanley SA, Cox JS. A non-RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis. Mol Microbiol 2005;57:1653-1663.
77. Hacker J, Kaper JB. Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 2000;54:641-679.
78. Garces A, et al. EspA acts as a critical mediator of ESX1-dependent virulence in Mycobacterium tuberculosis by affecting bacterial cell wall integrity. PLoS Pathog 2010;6:e1000957.
79. Chen JM, et al. Phenotypic profiling of Mycobacterium tuberculosis EspA point mutants reveals that blockage of ESAT-6 and CFP-10 secretion in vitro does not always correlate with attenuation of virulence. J Bacteriol 2013;195:5421-5430.
80. Gao LY, Guo S, McLaughlin B, Morisaki H, Engel JN, Brown EJ. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol Microbiol 2004;53:1677-1693.
81. Daleke MH, et al. Specific chaperones for the type VII protein secretion pathway. J Biol Chem 2012;287:31939-31947.
82. Korotkova N, et al. Structure of the Mycobacterium tuberculosis type VII secretion system chaperone EspG in complex with PE25-PPE41 dimer. Mol Microbiol 2014;26:12770.
83. Galagan JE, et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 2013;499:178-183.
84. Hayes CS, Aoki SK, Low DA. Bacterial contact-dependent delivery systems. Annu Rev Genet 2010;44:71-90.
85. Solans L, et al. A specific polymorphism in Mycobacterium tuberculosis H37Rv causes differential ESAT-6 expression and identifies WhiB6 as a novel ESX-1 component. Infect Immun 2014;82:3446-3456.
86. Davis NK, Chater KF. The Streptomyces coelicolor whiB gene encodes a small transcription factor-like protein dispensable for growth but essential for sporulation. Mol Gen Genet 1992;232:351-358.
87. Walters SB, Dubnau E, Kolesnikova I, Laval F, Daffe M, Smith I. The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis. Mol Microbiol 2006;60:312-330.
88. Gonzalo-Asensio J, et al. PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. PLoS ONE 2008;3:e3496.
89. Frigui W, et al. Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. PLoS Pathog 2008;4:e33.
90. Manca C, et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999;162:6740-6746.
91. Menon S, Wang S. Structure of the response regulator PhoP from Mycobacterium tuberculosis reveals a dimer through the receiver domain. Biochemistry 2011;50:5948-5957.
92. Raghavan S, Manzanillo P, Chan K, Dovey C, Cox J. Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature 2008;454:717-721.
93. Blasco B, et al. Virulence regulator EspR of Mycobacterium tuberculosis is a nucleoid-associated protein. PLoS Pathog 2012;8:e1002621.
94. Chesne-Seck ML, et al. A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra. J Bacteriol 2008;190:1329-1334.
95. Lee JS, et al. Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain. Cell Host Microbe 2008;3:97-103.
96. Arbues A, et al. Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials. Vaccine 2013;31:4867-4873.
97. de Jong BC, et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 2008;198:1037-1043.
98. Gonzalo-Asensio J, et al. Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator. Proc Natl Acad Sci USA 2014;111:11491-11496.
99. Bos KI, et al. Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis. Nature 2014;514:494-497.
100. Brosch R, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002;99:3684-3689.
101. Simeone R, Bottai D, Brosch R. ESX/type VII secretion systems and their role in host-pathogen interaction. Curr Opin Microbiol 2009;12:4-10.
102. Stanley SA, Johndrow JE, Manzanillo P, Cox JS. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J Immunol 2007;178:3143-3152.
103. Majlessi L, et al. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol 2005;174:3570-3579.
104. MacGurn JA, Cox JS. A genetic screen for Mycobacterium tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system. Infect Immun 2007;75:2668-2678.
105. Brodin P, et al. High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. PLoS Pathog 2010;6:e1001100.
106. Stewart GR, Patel J, Robertson BD, Rae A, Young DB. Mycobacterial mutants with defective control of phagosomal acidification. PLoS Pathog 2005;1:269-278.
107. van der Wel N, et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007;129:1287-1298.
108. Houben D, et al. ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol 2012;14:1287-1298.
109. de Jonge MI, et al. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol 2007;189:6028-6034.
110. Myrvik QN, Leake ES, Wright MJ. Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. A correlate of virulence. Am Rev Respir Dis 1984;129:322-328.
111. McDonough KA, Kress Y, Bloom BR. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 1993;61:2763-2773.
112. Armstrong JA, Hart PD. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 1971;134:713-740.
113. Rohde K, Yates RM, Purdy GE, Russell DG. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev 2007;219:37-54.
114. Stamm LM, et al. Mycobacterium marinum escapes from phagosomes and is propelled by actin-based motility. J Exp Med 2003;198:1361-1368.
115. Hagedorn M, Rohde KH, Russell DG, Soldati T. Infection by tubercular mycobacteria is spread by nonlytic ejection from their amoeba hosts. Science 2009;323:1729-1733.
116. Fortune SM, Rubin EJ. The complex relationship between mycobacteria and macrophages: it's not all bliss. Cell Host Microbe 2007;2:5-6.
117. Welin A, Lerm M. Inside or outside the phagosome? The controversy of the intracellular localization of Mycobacterium tuberculosis. Tuberculosis 2012;92:113-120.
118. + T cell response. J Immunol 2006;177:5647-5651.
119. Ryan AA, et al. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection. J Immunol 2009;182:7172-7177.
120. Billeskov R, Vingsbo-Lundberg C, Andersen P, Dietrich J. Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J Immunol 2007;179:3973-3981.
121. + T cells specific for the Mycobacterium tuberculosis antigen CFP10. Infect Immun 2008;76:4199-4205.
122. Winau F, et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006;24:105-117.
123. Harriff MJ, Purdy GE, Lewinsohn DM. Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens? Front Immunol 2012;3:40.
124. Basha G, et al. A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nat Immunol 2012;13:237-245.
125. Dorhoi A, et al. Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. Eur J Immunol 2012;42:374-384.
126. Mishra BB, et al. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 2010;12:1046-1063.
127. Wong KW, Jacobs WR Jr. Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis. Cell Microbiol 2011;13:1371-1384.
128. Mayer-Barber KD, et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 2014;511:99-103.
129. Manzanillo PS, Shiloh MU, Portnoy DA, Cox JS. Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe 2012;11:469-480.
130. Briken V, Ahlbrand SE, Shah S. Mycobacterium tuberculosis and the host cell inflammasome: a complex relationship. Front Cell Infect Microbiol 2013;3:62.
131. Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol 2010;8:668-674.
132. Watson RO, Manzanillo PS, Cox JS. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 2012;150:803-815.
133. Romagnoli A, et al. ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. Autophagy 2012;8:1357-1370.
134. Ravn P, et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 1999;179:637-645.
135. Ulrichs T, et al. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol 1998;28:3949-3958.
136. Pollock JM, Andersen P. Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect Immun 1997;65:2587-2592.
137. Millington KA, et al. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 2011;108:5730-5735.
138. Sidders B, et al. Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex. Infect Immun 2008;76:3932-3939.
139. Burts ML, Williams WA, Debord K, Missiakas DM. EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. Proc Natl Acad Sci USA 2005;102:1169-1174.
140. Griffin JE, et al. Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol 2012;19:218-227.
141. Siegrist MS, et al. Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition. Proc Natl Acad Sci USA 2009;106:18792-18797.
142. Zhang YJ, et al. Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathog 2012;8:e1002946.
143. Maciag A, et al. Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon. J Bacteriol 2007;189:730-740.
144. Rodriguez GM, Voskuil MI, Gold B, Schoolnik GK, Smith I. ideR, an essential gene in Mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response. Infect Immun 2002;70:3371-3381.
145. Serafini A, Boldrin F, Palu G, Manganelli R. Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by iron and zinc. J Bacteriol 2009;191:6340-6344.
146. Ilghari D, et al. Solution structure of the Mycobacterium tuberculosis EsxG.EsxH complex: functional implications and comparisons with other M. tuberculosis Esx family complexes. J Biol Chem 2011;286:29993-30002.
147. Siegrist MS, et al. Mycobacterial Esx-3 requires multiple components for iron acquisition. MBio 2014;5:e01073-e01014.
148. Mehra A, et al. Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking. PLoS Pathog 2013;9:e1003734.
149. + T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect Immun 2006;74:3396-3407.
150. Majlessi L, et al. Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules. J Immunol 2007;179:1825-1833.
151. Skjot RL, et al. Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infect Immun 2002;70:5446-5453.
152. +-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. Infect Immun 2003;71:7173-7177.
153. Dietrich J, et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 2005;174:6332-6339.
154. Sweeney KA, et al. A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med 2011;17:1261-1268.
155. Bottai D, Serafini A, Cascioferro A, Brosch R, Manganelli R. Targeting type VII/ESX secretion systems for development of novel antimycobacterial drugs. Curr Pharm Des 2014;20:4346-4356.
156. Stoop EJ, Bitter W, van der Sar AM. Tubercle bacilli rely on a type VII army for pathogenicity. Trends Microbiol 2012;20:477-484.
157. Abdallah AM, et al. A specific secretion system mediates PPE41 transport in pathogenic mycobacteria. Mol Microbiol 2006;62:667-679.
158. Abdallah AM, et al. The ESX-5 secretion system of Mycobacterium marinum modulates the macrophage response. J Immunol 2008;181:7166-7175.
159. Abdallah AM, et al. PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5. Mol Microbiol 2009;73:329-340.
160. Abdallah AM, et al. Mycobacterial secretion systems ESX-1 and ESX-5 play distinct roles in host cell death and inflammasome activation. J Immunol 2011;187:4744-4753.
161. Weerdenburg EM, et al. ESX-5-deficient Mycobacterium marinum is hypervirulent in adult zebrafish. Cell Microbiol 2012;14:728-739.
162. Di Luca M, et al. The ESX-5 associated eccB-eccC locus is essential for Mycobacterium tuberculosis viability. PLoS ONE 2012;7:e52059.
163. Bottai D, et al. Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. Mol Microbiol 2012;83:1195-1209.
164. Sayes F, et al. Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion-encoded PE-PPE proteins predicts vaccine potential. Cell Host Microbe 2012;11:352-363.
165. Banu S, Honore N, Saint-Joanis B, Philpott D, Prevost MC, Cole ST. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol Microbiol 2002;44:9-19.
166. Bottai D, Brosch R. Mycobacterial PE, PPE and ESX clusters: novel insights into the secretion of these most unusual protein families. Mol Microbiol 2009;73:325-328.
167. Gey van Pittius NC, Sampson SL, Lee H, Kim Y, van Helden PD, Warren RM. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol 2006;6:95.
168. Stinear TP, et al. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 2008;18:729-741.
169. Sampson SL. Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin Dev Immunol 2011;2011:497203.
170. Ramakrishnan L, Federspiel NA, Falkow S. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 2000;288:1436-1439.
171. Brennan MJ, et al. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells. Infect Immun 2001;69:7326-7333.
172. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 1999;34:257-267.
173. Dong D, et al. PPE38 modulates the innate immune response and is required for Mycobacterium marinum virulence. Infect Immun 2012;80:43-54.
174. Goldstone RM, Goonesekera SD, Bloom BR, Sampson SL. The transcriptional regulator Rv0485 modulates the expression of a pe and ppe gene pair and is required for Mycobacterium tuberculosis virulence. Infect Immun 2009;77:4654-4667.
175. Li Y, Miltner E, Wu M, Petrofsky M, Bermudez LE. A Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice. Cell Microbiol 2005;7:539-548.
176. Iantomasi R, et al. PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis. Cell Microbiol 2012;14:356-367.
177. Cascioferro A, et al. PE is a functional domain responsible for protein translocation and localization on mycobacterial cell wall. Mol Microbiol 2007;66:1536-1547.
178. Sali M, et al. Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice. Infect Immun 2010;78:5202-5213.
179. Dona V, et al. The PPE domain of PPE17 Is responsible for its surface localization and can be used to express heterologous proteins on the mycobacterial surface. PLoS ONE 2013;8:e57517.
180. Daleke MH, et al. Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via the ESX-5 pathway. J Biol Chem 2011;286:19024-19034.
181. Vordermeier HM, et al. Conserved immune recognition hierarchy of mycobacterial PE/PPE proteins during infection in natural hosts. PLoS ONE 2012;7:e40890.
182. + Th1 subset. PLoS Pathog 2013;9:e1003130.
183. Andersen P, Woodworth JS. Tuberculosis vaccines - rethinking the current paradigm. Trends Immunol 2014;35:387-395.
184. Delogu G, Brennan MJ. Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Infect Immun 2001;69:5606-5611.
185. Voskuil MI, Schnappinger D, Rutherford R, Liu Y, Schoolnik GK. Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis 2004;84:256-262.
186. Baena A, Porcelli SA. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 2009;74:189-204.
187. Woolard MD, Frelinger JA. Outsmarting the host: bacteria modulating the immune response. Immunol Res 2008;41:188-202.
188. Copin R, et al. Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition. MBio 2014;5:e00960-e00913.
189. Bottai D, Stinear T, Supply P, Brosch R. Mycobacterial pathogenomics and evolution. Microbiol Spectrum 2014;2:MGM2-0025-2013.
190. Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 2010;64:163-184.
191. Deatherage BL, Cookson BT. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect Immun 2012;80:1948-1957.
192. Rivera J, Cordero RJ, Nakouzi AS, Frases S, Nicola A, Casadevall A. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc Natl Acad Sci USA 2010;107:19002-19007.
193. Lee EY, et al. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics 2009;9:5425-5436.
194. Brown L, Kessler A, Cabezas-Sanchez P, Luque-Garcia JL, Casadevall A. Extracellular vesicles produced by the Gram-positive bacterium Bacillus subtilis are disrupted by the lipopeptide surfactin. Mol Microbiol 2014;93:183-198.
195. Olaya-Abril A, et al. Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae. J Proteomics 2014;106:46-60.
196. Marsollier L, et al. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog 2007;3:e62.
197. Prados-Rosales R, et al. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest 2011;121:1471-1483.
198. Prados-Rosales R, Weinrick BC, Pique DG, Jacobs WR Jr, Casadevall A, Rodriguez GM. Role for Mycobacterium tuberculosis membrane vesicles in iron acquisition. J Bacteriol 2014;196:1250-1256.
199. Rath P, et al. Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2013;110:E4790-E4797.
200. Holst J, et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 2009;27:B3-12.
201. Fransen F, et al. Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS ONE 2010;5:e15692.
202. Alaniz RC, Deatherage BL, Lara JC, Cookson BT. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 2007;179:7692-7701.
203. Schild S, Nelson EJ, Camilli A. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun 2008;76:4554-4563.
204. Sotolongo F, Campa C, Casanueva V, Fajardo EM, Cuevas IE, Gonzalez N. Cuban meningococcal BC vaccine: experiences & contributions from 20 years of application. MEDICC Rev 2007;9:16-22.
205. Rodriguez L, et al. Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice. Vaccine 2011;29:6236-6241.
206. Fine PEM, Carneiro IAM, Milstein JB, Clements CJ. Issues Relating to the Use of BCG in Immunization Programmes. A Discussion Document. Geneva: Department of Vaccines and Biologicals, World Health Organization, 1999:WHO/V&B/99.23.